₹1,670 crore
Despite this, we demonstrated resilience and delivered topline growth, with total income reaching ₹1,670 crores—reflecting a modest 1% year-on-year increase. Our EBITDA margin stood at 8.7%, underscoring our c
1%
ilience and delivered topline growth, with total income reaching ₹1,670 crores—reflecting a modest 1% year-on-year increase. Our EBITDA margin stood at 8.7%, underscoring our continued focus on operat
8.7%
ome reaching ₹1,670 crores—reflecting a modest 1% year-on-year increase. Our EBITDA margin stood at 8.7%, underscoring our continued focus on operational discipline amid a volatile environment The globa
₹1,013 crore
domestic operations have delivered a strong performance. Our standalone entity recorded revenues of ₹1,013 crores, driven by robust growth in the Indian market. We are seeing tangible results from the strategic
27%
cantly supported our growth In Q4 FY25, our ‘India-made, India-sold’ business posted a remarkable 27% year-on-year growth, and on a full-year basis, we achieved 20% growth. This underscores India’s po
20%
a-sold’ business posted a remarkable 27% year-on-year growth, and on a full-year basis, we achieved 20% growth. This underscores India’s position as a bright spot in the global refractory landscape. The
14%
e years ahead. From a profitability perspective, our standalone EBITDA margins remained healthy—at 14% for the full year and around 15% in Q4FY25 While near-term pressures continue in global markets, w
15%
ty perspective, our standalone EBITDA margins remained healthy—at 14% for the full year and around 15% in Q4FY25 While near-term pressures continue in global markets, we remain focused on building capa
₹7
ders’ continued trust and support, I am pleased to share that our Board has approved a dividend of ₹7 per share and has also announced a 1:1 bonus issue. We remain committed to delivering value to all
11%
ce Highlights Total Revenue (Rs. Crs) EBITDA before Exceptional Items (Rs. Crs) PAT (Rs. Crs) +11% 1,014 910 -17% 169 140 -12% 65 58 +26% 216 273 +7% 38 40 +9% 16 17 Q4FY24 Q4FY25
17%
al Revenue (Rs. Crs) EBITDA before Exceptional Items (Rs. Crs) PAT (Rs. Crs) +11% 1,014 910 -17% 169 140 -12% 65 58 +26% 216 273 +7% 38 40 +9% 16 17 Q4FY24 Q4FY25 FY24 FY25 Q4FY
12%
Crs) EBITDA before Exceptional Items (Rs. Crs) PAT (Rs. Crs) +11% 1,014 910 -17% 169 140 -12% 65 58 +26% 216 273 +7% 38 40 +9% 16 17 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24